Medtronic Bridge
This article was originally published in The Gray Sheet
Executive Summary
Balloon-expandable peripheral stent gains FDA go-ahead for renal vessels following sub-optimal balloon angioplasty based on the 188-patient SOAR registry. The data showed that Bridge use is associated with a 16.8% restenosis rate 12 months post-procedure, compared to historic rates of 26-48%. The new indication supplements the device's 1998 approval for biliary procedures...
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.